Homocysteine: the latest risk factor for heart disease

Area of Science:

• Biochemistry
• Cardiology
• Nursing Science

Background:

• Homocysteine, a sulfur-containing amino acid, is increasingly recognized as a risk factor for cardiovascular disease (CVD).
• Elevated homocysteine levels (hyperhomocysteinemia) may explain a portion of unexplained cardiovascular mortality.
• The clinical significance of hyperhomocysteinemia in CVD necessitates greater awareness among healthcare professionals.

Purpose of the Study:

• To review the current evidence linking homocysteine to cardiovascular disease.
• To highlight the importance of understanding hyperhomocysteinemia for critical care nurses.
• To emphasize the integration of this knowledge into clinical practice.

Main Methods:

• Literature review of recent evidence on homocysteine and CVD.
• Analysis of the pathophysiology and risk factors associated with hyperhomocysteinemia.
• Discussion of current treatment strategies and ongoing research.

Main Results:

• Evidence strongly supports homocysteine as a risk factor for cardiovascular disease.
• Hyperhomocysteinemia is implicated as a potential factor in persistent high CVD mortality rates.
• The pathophysiology, treatment, and research surrounding hyperhomocysteinemia are critical for clinical application.

Conclusions:

• Critical care nurses must be educated on hyperhomocysteinemia and its role in CVD.
• Incorporating knowledge of homocysteine's impact into practice can improve patient care and outcomes.
• Further research and clinical vigilance are needed to manage hyperhomocysteinemia effectively.